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William S. Korinek, Erfei Bi*, J. Andrew Epp, Lisa Wang, Joyce Ho
and John Chant
Cytokinesis requires the wholesale reorganization of
the cytoskeleton and secretion to complete the division
of one cell into two. In the budding yeast
Saccharomyces cerevisiae, the IQGAP-related protein
Iqg1 (Cyk1) promotes cytokinetic actin ring formation
and is required for cytokinesis and viability [1–3]. As
the actin ring is not essential for cytokinesis or
viability, Iqg1 must act by another mechanism [4]. To
uncover this mechanism, a screen for high-copy
suppressors of the iqg1 lethal phenotype was
performed. CYK3 suppressed the requirement for IQG1
in viability and cytokinesis without restoration of the
actin ring, demonstrating that CYK3 promotes
cytokinesis through an actomyosin-ring-independent
pathway. CYK3 encodes a novel SH3-domain protein
that was found in association with the actin ring and
the mother–bud neck. cyk3 null cells had misshapen
mother–bud necks and were deficient in cytokinesis. In
the cyk3 null strain, actin rearrangements associated
with cytokinesis appeared normal, suggesting that the
phenotype reflects a defect in secretory targeting or
septal synthesis. Deletion of either cyk3 or hof1 alone
results in a mild cytokinetic phenotype [5–7], but
deletion of both genes resulted in lethality and a
complete cytokinetic block, suggesting overlapping
function. Thus, Cyk3 appears to be important for
cytokinesis and acts potentially downstream of Iqg1.
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Results and discussion
The execution of cytokinesis, along with its spatial and
temporal control, are complex physiological processes
about which very little is known in molecular terms. Evi-
dence suggests that a number of activities, such as actin
ring contraction and localized secretion, contribute to
cytokinesis and that the relative importance of each con-
tribution varies between different organisms (for recent
reviews, see [8,9]). To date, budding and fission yeast
have been fundamental in deciphering the process of
cytokinesis at the molecular level.
In S. cerevisiae, cytokinesis occurs at the narrow mother–bud
neck, already fixed by the budding axis. A ring of actin and
type II myosin (Myo1) assembles at the bud neck and
appears to contract [1,2,4,10]. Cortical actin patches, initially
concentrated at the bud surface, become clustered around
the bud neck, presumably to direct secretory vesicles to this
region [11,12]. A primary septum, mainly consisting of
chitin, is synthesized centripetally in the bud neck [7,13]
with secondary septa composed of mannans and glucans
forming alongside. Cell separation occurs through degrada-
tion of the primary septum by endochitinase [14,15].
IQGAP proteins were originally identified in mammalian
cells as potential effectors of Cdc42 [16–20]. In budding
and fission yeasts, IQGAP-type proteins have been shown
to be central factors in cytokinesis [1–3,21]. These 
proteins colocalize with the cytokinetic actomyosin ring
and are required for its assembly [1–3,21]. Depletion of
Iqg1 activity in budding yeast results in chains of cells that
have failed to undergo cytokinesis and lyse after several
rounds of nuclear division [1,2]. Fission yeast rng2 mutants,
which are also defective in cytokinetic actin ring formation,
fail to form a septum, become multinucleate and die [21]. 
Although budding yeast IQG1 is required for cytokinesis
and for actin ring formation, the actomyosin ring is dis-
pensable for cytokinesis and viability [4] — a surprising
finding given the widespread belief that a contractile ring
is essential to cytokinesis in animal cells and fission yeast
[22]. These findings suggest that Iqg1 must have activi-
ties critical to cytokinesis but independent of actomyosin
ring formation.
To learn more about Iqg1 and cytokinesis, high-copy sup-
pressors of the iqg1 deletion were isolated (see Supplemen-
tary material). Several distinct high-copy suppressors were
identified. On closer scrutiny, only YDL117w conferred
strong suppression (Figure 1a). This gene had also been
isolated as a high-copy suppressor of a hof1 (cyk2) mutation
under restrictive conditions (Figure 1b and unpublished
data). YDL117w was named CYK3 for its role in cytokinesis.
The Cyk3 sequence predicted a SH3 domain at its amino
terminus, but was otherwise novel (Figure 1e). A homolog
(SPAC9G1.06c; 26% identity, 45% similarity) was found in
the Schizosaccharomyces pombe database. No related pro-
teins were found in other databases. Remarkably, most
iqg1∆ cells that were suppressed by CYK3 appeared
normal. Only 32% of the cells exhibited a cytokinesis
defect, compared with 100% for an iqg1 null (see Supple-
mentary material). Suppression occurred without restora-
tion of cytokinetic actin rings (Figure 1c). 
Because CYK3 was also found as a suppressor of hof1, we
tested whether multicopy HOF1 could suppress the iqg1
deletion. We found that it did (Figure 1a). Cells sup-
pressed by HOF1 exhibited a 42% cytokinesis defect (see
Supplementary material). No actin rings were detected in
cells suppressed by HOF1 either (Figure 1d). 
A cyk3 null strain was constructed and its phenotype ana-
lyzed. The cyk3 null mutant was viable although growth was
slowed (data not shown). The cyk3 cells were 9-10% defi-
cient in cytokinesis (see Supplementary material) and were
moderately aberrant in morphology (Figure 2a,b); 50% of
cyk3 cells exhibited a noticeably aberrant mother–bud neck,
which often appeared large, bent, or misshapen (Figure 2a,
arrowheads). Such aberrations potentially represent a defect
in targeting or incorporation of septal components. Actin
structures appeared normal in cyk3 null strains (Figure 2c).
Cyk3 localization was determined by producing a fusion
between Cyk3 and green fluorescent protein (Cyk3–GFP)
expressed from the endogenous CYK3 locus; 69% of
unbudded cells (n = 103) had a Cyk3–GFP signal
(Figure 3a, cell 7). From the appearance alone, it was not
clear whether this signal represented localization at the
incipient bud site, a remnant from the previous division
site, or both. Cells with a tiny bud did not have
Cyk3–GFP signal in association with the bud (Figure 3a,
cell 1), and some cells with a tiny bud still had the
Cyk3–GFP signal at the previous division site (Figure 3a,
cell 8). Together, these data suggest that Cyk3–GFP
remains at the division site after cell separation, rather
than localizing to the nascent bud site. 
Within the cell cycle, Cyk3 could first be seen in the bud
neck as the cell enters late anaphase or telophase. Three
types of signal were observed in the bud neck: a single
band (Figure 3a, cell 4); a bright short band or a dot in the
center of the bud neck flanked by two faint V-shaped
signals (Figure 3a, cell 5); and double bands (Figure 3a,
cell 6). Among the cells with a Cyk3–GFP signal (n = 112),
37% had a single band or a single dot at the bud neck,
whereas 63% had double bands.
Given the rather mild cyk3 cytokinetic defect relative to
CYK3’s potent suppression ability, the cyk3 mutation was
combined with several others that mildly affect cytokinesis.
HOF1 mutants have a slight cytokinesis defect at normal
temperatures ([5–7] and data not shown). Remarkably, the
hof1 cyk3 combination was lethal. Germinated double
mutant spores showed a terminal phenotype of a severe
cytokinetic defect, very like that of iqg1 [1,2] (Figure 4b).
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CYK3 and HOF1 act as iqg1 suppressors. (a) Overexpression of CYK3
or HOF1 efficiently suppressed the lethality of the iqg1 null mutation.
High-copy HOF1 (pBK6), CYK3 (pBK42) or empty vector (YEplac112)
were transformed into an iqg1 deletion mutant supported by a low copy
IQG1 plasmid (strain 2221). Transformants were streaked on medium
containing 5-fluoro-orotic acid to assess the ability of CYK3 or HOF1 to
rescue the lethality of the iqg1 null. (b) High-copy CYK3 suppressed the
hof1 null mutation. Wild-type or hof1 nulls supported by HOF1 or CYK3
were streaked onto media containing 3% formamide, to which hof1
mutants are sensitive. The strains and plasmids were: wild-type, 1237-
13C; hof1-1, BK274; hof1∆, BK369; pHOF1, pBK41; pCYK3, pBK42.
(c) The phenotype of iqg1 null cells suppressed by CYK3 (BK483). F-
actin, filamentous actin; DIC, differential interference contrast.
(d) The phenotype of iqg1 null cells suppressed by HOF1 (BK484).
(e) Alignment of S. cerevisiae Cyk3 and S. pombe Cyk3. Identical and
conserved amino acids are indicated. The predicted SH3 domain is
underlined [26]. The numbers indicate amino-acid positions, and dots
indicate gaps that were introduced to optimize the alignment.
We also examined genetic combinations of cyk3 with bni1,
bnr1, or myo1, all of which have been implicated in cytoki-
nesis [2,4,5,7,23–25]. No genetic interactions were
observed with bni1 or bnr1 (data not shown), but cyk3 was
lethal in combination with myo1. Of 72 dissected tetrads,
19 viable myo1 colonies were isolated, whereas no cyk3
myo1 colonies were isolated. Germinating cyk3 myo1 spores
exhibited a severe cytokinesis defect resulting in a termi-
nal phenotype similar to those of iqg1 or hof1 cyk3 [1,2].
The evidence presented here suggests that Cyk3 is a
novel cytokinetic factor, possibly contributing to secre-
tory targeting or septal deposition. The lack of major
defects in cyk3 nulls is likely to reflect the existence of
overlapping cytokinetic pathways. Loss of CYK3 in com-
bination with deletions in other cytokinetic genes with
mild phenotypes, such as HOF1 or MYO1, resulted in
lethality and a complete cytokinetic block. The fact that
overexpressed CYK3 supported viability in the cytokine-
sis-defective iqg1 strain so efficiently also argues for CYK3
having a central role in cell division. We propose that
optimal cytokinesis requires the interplay of several path-
ways defined by MYO1, HOF1, CYK3 and possibly other
genes. In the absence of any one of these pathways, the
others compensate.
Our findings suggest two further conclusions regarding
Cyk3 function. First, the Cyk3 and Hof1 pathways function
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Figure 2
Morphology of (a) cyk3∆ (BK87) and (b) wild-type (1237-13C) cells.
Arrowheads, cells with aberrant mother–bud necks. (c) Actin
organization in cyk3 null cells through the cell cycle. Open arrowhead,
actin ring; closed arrowhead, cytokinetic clusters of actin patches. The
scale bar represents 5 µm.
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Figure 3
Subcellular localization of Cyk3 protein. (a) Cyk3, actin and DNA
localization through the cell cycle. (b) Cyk3 localization compared with
septum formation. The Cyk3–GFP strain is YEF2269. The scale bar
represents 3 µm.
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independently of the actomyosin ring (Myo1 pathway).
Second, the abilities of Hof1 and Cyk3 to suppress the iqg1
null suggest that these two proteins can act downstream of
Iqg1. The identification of Cyk3 and its genetic relation-
ships should allow further molecular dissection of the mul-
tiple pathways contributing to cytokinesis in budding yeast.
Supplementary material
Additional methodological details and tables comparing the efficiency
of suppressed cytokinesis in wild-type, cyk3∆ and iqg1∆ strains are
available at http://current-biology.com/supmat/supmatin.htm. 
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Figure 4
Terminal phenotypes of cyk3∆ hof1∆ and cyk3∆ myo1∆ spores.
Germination and outgrowth phenotype is shown for (a) wild-type,
(b) cyk3∆ hof1∆, and (c) cyk3∆ myo1∆ spores. The parent strain for
cyk3∆ hof1∆ spores is BK462. The parent strain for wild-type and
cyk3∆ myo1∆ spores is BK464.
(b) cyk3∆ hof1∆ (a) Wild type
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Supplementary materials and methods
Media, growth conditions, genetic methods and DNA
manipulations
Strains, plasmids and oligonucleotide primers used in this study are
listed in Table S1. DNA was manipulated by standard methods [S1].
Standard media and genetic methods were used, and strains were
grown at 30°C unless noted [S2]. Addition of formamide to media was
to a final concentration of 3% [S3]. S. cerevisiae transformations were
performed by the lithium acetate method for integrative or library trans-
formations [S4] or the one-step protocol for other transformations [S5]. 
Isolation of high-copy suppressors of an iqg1∆ strain 
Strain 2222 (iqg1∆::kanR leu2 strain carrying p1868) was generated
for this screen as follows. One copy of the LEU2 gene was deleted in
strain 1733 [S6] by one-step gene replacement using a fragment con-
taining the URA3 gene flanked by the 5′ and 3′ non-coding sequence
of LEU2, derived from pNKY85 [S7]. Transformants were selected on
SD-Ura media, and then streaked onto 5-FOA media to select for cells
which lost the URA3 gene by homologous recombination at the direct
repeats flanking URA3. Resulting colonies were transformed with
p1868, sporulated, and dissected to yield strain 2222.
This strain was transformed with a YEp13 library [S8] and plated onto
SD-Leu media; 60,000 transformants were screened by replica
plating onto 5-FOA plates twice in series, and viable colonies were
streak purified. The YEp13 library plasmids were recovered from
viable isolates and the ability to confer viability reconfirmed. Plasmids
were sequenced to delineate the genomic inserts responsible for the
suppression using oligos YEp13-A and YEp13-B. Five independent
suppressors were obtained, in addition to one plasmid containing
IQG1. Three plasmids recovered acted as very weak suppressors,
and no further work has been done with them. Two plasmids were iso-
lated that contained the complete coding sequence of YDL117w
(pBK132 and pBK133). To verify that YDL117w was indeed responsi-
ble for the suppression, a minimal 3.8 kb SphI fragment containing the
complete coding sequence of YDL117w was subcloned from
pBK133 and ligated into the SphI site of YEplac112, generating
pBK42. This plasmid was able to suppress the iqg1∆.
To test the ability of HOF1 to suppress an iqg1 null, a high-copy HOF1
plasmid (pBK6) was created as follows. HOF1 was PCR amplified from
the genomic library plasmid pBK27 using primers BKI-35 and BKI-36.
The PCR product was cut with SacI and XmaI and ligated into the
vector pRS316 [S9] to make plasmid pBK66. A triple HA epitope
coding fragment flanked by NotI sites was isolated from plasmid
pMM71 [S10] and ligated to the 3′ end of the HOF1 open reading
frame (ORF) via the introduced NotI site of pBK66, creating pBK41. The
HOF1-3xHA DNA fragment was excised from pBK41 via the KpnI and
SacI sites. The fragment ends were blunted, and the fragment ligated
into the SmaI site of YEplac112, creating pBK6, which was tested for
its ability to suppress an iqg1∆ strain. The ability of multicopy suppres-
sors to support growth in an iqg1∆ strain (2221) was assessed by a
‘plasmid shuffle’ experiment. Strain 2221 containing p1868 (IQG1 on a
CEN URA3 plasmid) was transformed with the appropriate plasmid, and
transformants were transferred to 5-FOA media to select for cells that
were viable after losing the URA3 IQG1-containing plasmid.
Disruption of HOF1
A PCR fragment was generated for disruption of the first 934 bp of
the 2010 bp HOF1 ORF by the amplification of the kanamycin/G-418
resistance cassette from the plasmid pUG6 [S11] with the primers
BKI-53 and BKI-54. A complete deletion of the ORF was not pro-
duced because of concerns with regards to the expression of the
downstream gene ARP9 and an uncharacterized ORF overlapping
the HOF1 3′ region. The fragment was transformed into wild-type
strains, and transformants selected on YPD plates containing
200 mg/l G-418 (Geneticin, Life Technologies). Transformants for
the HOF1 replacement in 52 or 1237-13C strain backgrounds,
including BK59 and BK369, respectively, were identified by diagnos-
tic PCR using the primers BKI-20 and BKI-55.
Isolation of hof1∆ high-copy-number suppressors
Utilizing formamide sensitivity as a conditional phenotype [S3], a hof1
mutant, BK274, was previously isolated (W.S.K. and J.C., unpublished
data). The hof1 deletion strains were also found to be formamide sensi-
tive. The isolation of hof1 high-copy-number suppressor plasmids used
the hof1 null BK384 as the formamide-sensitive starting strain. BK384
was derived as a byproduct of the following crosses. A segregant of
BK59 (described above) was crossed to BK217 (MATa
yhr114w∆::TRP1 leu2 trp1 ura3). A resulting segregant was crossed
to DBY6938 [S12]. BK384 is a segregant of this latter cross. Two
plasmids that both contain full-length CYK3 (pBK132 and pBK133)
were repeatedly isolated from a high-copy library [S8] as suppressors
of hof1∆ (BK384) formamide sensitivity. To confirm that CYK3 was the
gene responsible, pBK42 (described above) was transformed into the
hof1 null strain. This plasmid suppressed the formamide sensitivity of
BK384, confirming that CYK3 encoded the suppression activity.
Disruption of CYK3
A PCR fragment was generated for disruption of the entire CYK3
ORF (GenBank accession number Z74165) by the amplification of
the kanamycin/G-418 resistance cassette from the plasmid pUG6
[S11] using the primers YDL117w-KO1 and YDL117w-KO2. The
replacement cassette was transformed into the diploid strain 52
[S13] and transformants selected on YPD containing 200 mg/l G-
418. Transformants heterozygous for the CYK3 replacement (includ-
ing BK86) were identified by diagnostic PCR with the primers
YDL117w-B and KAN-JH. BK87 is a segregant of BK86.
Counting methods
In all counts, cultures were grown exponentially at 30°C, fixed and
lightly sonicated. Samples for cytokinesis counts were placed on a
slide, covered gently with a glass cover slip (not pressed), and immedi-
ately viewed by DIC microscopy. The number of connected cell bodies
was counted on the drifting cells. Counts on wild-type or cyk3∆ strains
were performed with two independent cultures and averaged
(n > 1000 each count). Counts on iqg1∆ suppressed strains were on a
single culture (n > 300).
Construction of Cyk3–GFP
A pair of hybrid primers, CYK3–GFP-forward and CYK3–GFP-
reverse, were used to amplify sequences encoding the GFP tag from
plasmid pFA6a–GFP(F64L, S65T)–kanMX6 [S14,S15]. The ampli-
fied fragment was transformed into strain YEF473 [S16], and stable
Kanr colonies were selected, generating strain YEF2264. Two Kanr
segregants from YEF2264 were crossed to form strain YEF2269,
which is homozygous for CYK3–GFP. The correctness of the GFP
tagging was confirmed by two PCRs, one using the original pair of
primers, and the other using the same forward primer and a new
reverse primer, CYK3–CK-reverse, which is 155 bp downstream of
the CYK3 stop codon.
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Microscopy in S. cerevisae
Standard yeast fluorescent techniques were used to view cells
[S2,S17]. Exponentially growing cells were used for all observations
(OD600 0.3–0.6). To visualize Cyk3–GFP, F-actin and DNA in the
same cells, exponentially growing cells of YEF2269 (homozygous
Cyk3–GFP) were fixed in 70% ice-cold ethanol for 10 min. Cells
were then stained for F-actin with 2 U/ml rhodamine–phalloidin (Mole-
cular Probes) in PBS containing 10 mg/ml BSA for 10 min at 23°C,
followed by washing with 1 × PBS for three times. After the final
wash, the cell pellet was resuspended in 100 µl mounting medium
containing 1 µg/ml bisBenzimide (Sigma) [S17] and observed.
To visualize Cyk3–GFP and the septum simultaneously, 5 µl yeast
strain YEF2269 grown exponentially in synthetic complete (SC)
medium was spotted onto a thin layer of SC medium containing 25%
gelatin on a slide. Samples were observed by standard epifluorescence
microscopy. Cells expressing Cyk3–GFP were filmed with a high-reso-
lution charge-coupled device camera (model C4742-95, Hammamatsu
Photogenics). The DIC images (exposure time 0.6 sec) and GFP
images (exposure time 5 sec) were acquired and analyzed by a modi-
fied version of Image-Pro Plus imaging software (Media Cybernetics;
now called Phase 3 Imaging Systems). Cell fields were collected by
CCD camera (model RTE/CCD-1317-K/2, Princeton Instruments, Inc.)
and MetaMorph 3.0 software. The contrast of the images was
enhanced with Adobe Photoshop Version 4.0 (Adobe Systems). 
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Supplementary material S3
Table S1
Strains, plasmids and DNA primers used in this study.
S. cerevisiae strains used in this study:
Strain Relevant genotype Source
1237-13C MATα his4 trp1 ura3 [S13]
52 MATa/MATα his4/his4 trp1/trp1 ura3/ura3 [S6]
1733 MATa/MATα iqg1∆::KANR/IQG1 his4/his4 trp1/trp1 ura3/ura3 [S6]
2221 MATa iqg1∆::KANR his4 trp1 ura3 carrying p1868 *
2222 MATa iqg1∆::KANR his4 trp1 ura3leu2 carrying p1868 *
BK86 MATa/MATα cyk3∆::KANR/CYK3 his4/his4 trp1/trp1 ura3/ura3 *
BK87 MATa cyk3∆::KANR his4 trp1 ura3 Segregant from BK86
BK88 MATα cyk3∆::KANR his4 trp1 ura3 Segregant from BK86
BK274 MATα hof1-1 leu2 trp1 ura3 *
BK369 MATα hof1∆::KANR his4 trp1 ura3 *
BK384 MATα hof1∆::KANR leu2 ura3 *
BK462 MATα/MATa hof1∆::KANR/HOF1 cyk3∆::KANR/CYK3 his3/HIS3 his4/HIS4 leu2/LEU2 BK88 × BK384
trp1/TRP1 ura3/ura3
BK464 MATα/MATα myo1∆::URA3/MYO1 cyk3∆::KANR/CYK3 ade1/ADE1 his2/HIS2 his4/HIS4 BK88 × JMY1235
leu2/LEU2 trp1/trp1 ura3/ura3
BK483 MATa iqg1∆::KANR his4 trp1 ura3 carrying pBK42 *
BK484 MATa iqg1∆::KANR his4 trp1 ura3 carrying pBK6 *
YEF473 MATa/MATα his3/his3 leu2/leu2 lys2/lys2 trp1/trp1 ura3/ura3 [S16]
YEF2269 MATa/MATα CYK3:GFP:KANR/ CYK3:GFP:KANRhis3/his3 leu2/leu2 lys2/lys2 trp1/trp1 ura3/ura3 *
JMY1235 MATa myo1∆::URA3 ade1 his2 leu2 trp1 ura3 †
Plasmids used in this study:
Plasmid Description Source
YEplac112 TRP1, high-copy plasmid (2 µ) [S18]
pBK6 HOF1-3xHA, TRP1, high-copy plasmid (2 µ) *
pBK27 Genomic fragment containing HOF1 in YCp50 ‡
pBK41 HOF1-HA fusion carried in pRS316 *
pBK42 Minimal subclone of CYK3 in YEplac112 *
p1868 Genomic fragment containing IQG1 in YCp50 ‡
DNA primers used in this study:
Name Sequence (5′→3′)
YEp13-A GGAGCCACTATCGACTACGCGATCATGGCG
YEp13-B GGCGCCAGCAACCGCACCTGTGGCG
BKI-35 CCCCGAGCTCTTCTTTGGACTTTCTCTTCGTC
BKI-36 GCGACCCGGGTCAGGATCCGCGGCCGCTAGCAAGACCTTGATGCAGTAGCTG
BKI-53 GTGAGACTTGGAAAGTGTACTACTAATATTCAGAAAAAGGTGAAAGACAGCTGAAGCTTCGTACGC
BKI-54 TATTGAAGCTAGTTTCCTTTTATTTTCGGTTTCCTTCAGCTGAGAAGATAGCATAGGCCACTAGTGGATCTG
BKI-20 GGATCTTGCCATCCTATGG
BKI-55 CGTATGACGGGTGTGGAA
YDL117w-KO1 TTAATTCCTGAATTTACCGTATTACATTTAAATTTGCATAGCATAGGCCACTAGTGGATCTG
YDL117w-KO2 ATACAGATTATAGCGCTGTAAAAAAATTTGTGAAAAACGTCAGCTGAAGCTTCGTACGC
YDL117w-B CTAACGCAAGCTGCCCCGCGGCTGAGCGAAACTCTCTTA
KAN-JH TCGCACCTGATTGCCCG
CYK3-GFP-forward TGGTATTGGGTGGTCCGTTTTTGCTGAATGGTTGTGCGTACGGATCCCCGGGTTAATTAA
CYK3-GFP-reverse ATACAGATTATAGCGCTGTAAAAAAATTTGTGAAAAACGTGAATTCGAGCTCGTTTAAAC
CYK3-CK-reverse GAAAACATCACTAAATACGAAAAA
*See Supplementary materials and methods. †Segregant of JMY1318 [S19]. ‡Isolated from Rose library [S20].
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Table S2
Analysis of cytokinesis efficiency in iqg1∆ strains supported by HOF1 or CYK3.
Percentage of cells with Percentage of cells with
Suppressor one or two cell bodies more than two cell bodies n
IQG1 98 2 346
HOF1 58 42 310
CYK3 68 32 348
Table S3
Analysis of cytokinesis efficiency in wild-type or cyk3∆ strains.
Percentage of cells with Percentage of cells with
Strain one or two cell bodies more than two cell bodies n
Wild type 99.1 0.9 2091
cyk3∆ 90.8 9.2 2220
